Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

Surgeon

European, Industry news 01/12/2022

New Developments in MedTech Patenting at the European Patent Office

Dermot Roche Press 800X800px Colour Temp Pic

European, Events, Team news 23/11/2022

Secerna to attend Knowledge Transfer Ireland Impact Awards

European Patent Office Building

European, Industry news 08/11/2022

How To Make Life Easier At The EPO – Exclusion of Diagnostic Methods

EPO 2021

European, Industry news 01/11/2022

Plausibility at the EPO - G2/21

B012799

Events 16/10/2022

Oncology & Precision Medicine Conferences 2022

News234

Industry news 14/10/2022

Pushing the boundaries of scientific discovery

News232

European 05/10/2022

Patenting Antibodies at the European Patent Office

News231

Team news 27/09/2022

Biotech specialist joins growing Yorkshire IP law firm

News230

Events 05/09/2022

Secerna to attend Medical Technology Ireland conference

18 19 20 21 22 23 24 25 26 27 28